Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA Pauses Clozapine REMS Program Enforcement Due to High Volume of Patient Delays The program was put in place to prevent cases of neutropenia, which was leaving patients vulnerable to severe and sometimes deadly infections. December 16, 2021 Martha Garcia Add Your Comments Delays in patients receiving treatment have led to federal regulators to put on hold a program that was intended to reduce the risk of adverse side effects from Clozapine; an antipsychotic known to cause neutropenia, which may leave patients vulnerable to infection. On December 2, the FDA announced it was temporarily suspending enforcement of some aspects of the Clozapine Risk Evaluation and Mitigation Strategy (REMS) program, allowing pharmacists and wholesalers to provide easier access to the drug for patients in the interim. Clozapine is used to treat patients diagnosed with severe schizophrenia whose symptoms cannot be controlled by standard antipsychotic treatment or therapies. The antipsychotic medication has also been used to treat reoccurring suicidal behavior in patients with schizophrenia or schizoaffective disorder. The drug is used to block various receptors in the brain and restore balance in patient’s dopamine and serotonin level. However, it also can decrease the neutrophil count, lowering the body’s resistance to infections. The Clozapine REMS program was put in place to manage the risk of severe neutropenia, which can result in serious injury or death. It required pharmacies and prescribers to be certified before receiving, dispensing or prescribing the drug. Pharmacists and prescribers were required to be certified by November 15 if they were to be allowed to dispense the drug. However, the FDA reports that healthcare professionals began to alert the agency about problems with the program, including high call volume and long call wait times for patients. As a result, many healthcare professionals were unable to meet the November 15 deadline for the program. As a result, the FDA announced it will place certain aspects of the program to be on temporary hold. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The FDA will not object if pharmacists dispense clozapine without a REMS dispense authorization. The agency will also not object if wholesalers ship clozapine to pharmacies and healthcare settings without confirming enrollment in the REMS program. The agency noted it is invested in the continuity of care, patient access to clozapine, and patient safety priority. Abruptly stopping clozapine can lead to complications for patients, and the FDA indicates doctors should use their clinical judgement with regard to prescribing the drug to patients with an absolute neutrophil count within the acceptable range. The clozapine REMS regulations required patients to undergo absolute neutrophil count monitoring. Due to the issues with hold and wait times, those requirements are also on hold. REMS is a drug safety program instituted by the FDA to monitor medications with a high potential for serious adverse effects. It applies to specific prescription drugs and can carry specific requirements, such as for clozapine. The FDA indicates it is working with the clozapine REMS program administrators to address the high call volume and long wait time challenges to avoid interruption in patient care. While certain aspects of the clozapine REMS program are on hold, the FDA also encourages pharmacists and prescribers to continue working with the clozapine REMS program to complete certification and patient enrollment. “We understand that this has caused frustration and has led to patient access issues for clozapine,” the agency said in its statement. “The FDA takes these concerns seriously.” Tags: Antipsychotic, Clozapine, Infections, Neutropenia, REMS More Lawsuit Stories Nitrous Oxide Abuse Crisis Fueled by Youth Marketing and Addictive Designs, Lawsuits Allege July 16, 2025 Schedule Leading to Valsartan Lawsuit Bellwether Trial in September 2025 Outlined by MDL Judge July 16, 2025 Two Decades of Stonecutting Led to Silica Dust Lung Damage, Lawsuit Alleges July 16, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Nitrous Oxide Abuse Crisis Fueled by Youth Marketing and Addictive Designs, Lawsuits Allege (Posted: today) Nitrous oxide lawsuits are rising nationwide as states report increased injuries and deaths from laughing gas abuse, fueled by social media and marketing that promote the drug as a way for teens and young adults to get high. MORE ABOUT: NITROUS OXIDE LAWSUITRecreational Nitrous Oxide Use Linked to Frostbite Injury Risks, Case Report Warns (07/09/2025)Nitrous Oxide Side Effects From Long-Term Use Linked to Paralysis, Nerve Damage in Lawsuits (07/02/2025)Whippet Lawsuit Alleges Nitrous Oxide Addiction Resulted in Paralysis, Nerve Damage (06/27/2025) Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (Posted: yesterday) As the Depo-Provera MDL moves toward its first jury trials, the litigation has reached a key milestone, with more than 550 lawsuits filed over brain tumor injuries linked to the birth control injection. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025) Suboxone Injury Lawyers Reappointed to Leadership Roles in Federal MDL (Posted: 2 days ago) A federal judge has confirmed the reappointment of more than two dozen Suboxone injury lawyers to serve in leadership positions representing plaintiffs for another year. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITGas Station Heroin Class Action Lawsuit Filed Over Addictive Properties of ZaZa Supplements (07/03/2025)Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (05/22/2025)500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)
Nitrous Oxide Abuse Crisis Fueled by Youth Marketing and Addictive Designs, Lawsuits Allege July 16, 2025
Schedule Leading to Valsartan Lawsuit Bellwether Trial in September 2025 Outlined by MDL Judge July 16, 2025
Nitrous Oxide Abuse Crisis Fueled by Youth Marketing and Addictive Designs, Lawsuits Allege (Posted: today) Nitrous oxide lawsuits are rising nationwide as states report increased injuries and deaths from laughing gas abuse, fueled by social media and marketing that promote the drug as a way for teens and young adults to get high. MORE ABOUT: NITROUS OXIDE LAWSUITRecreational Nitrous Oxide Use Linked to Frostbite Injury Risks, Case Report Warns (07/09/2025)Nitrous Oxide Side Effects From Long-Term Use Linked to Paralysis, Nerve Damage in Lawsuits (07/02/2025)Whippet Lawsuit Alleges Nitrous Oxide Addiction Resulted in Paralysis, Nerve Damage (06/27/2025)
Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (Posted: yesterday) As the Depo-Provera MDL moves toward its first jury trials, the litigation has reached a key milestone, with more than 550 lawsuits filed over brain tumor injuries linked to the birth control injection. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)
Suboxone Injury Lawyers Reappointed to Leadership Roles in Federal MDL (Posted: 2 days ago) A federal judge has confirmed the reappointment of more than two dozen Suboxone injury lawyers to serve in leadership positions representing plaintiffs for another year. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITGas Station Heroin Class Action Lawsuit Filed Over Addictive Properties of ZaZa Supplements (07/03/2025)Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (05/22/2025)500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)